DK0566666T3 - Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler - Google Patents

Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler

Info

Publication number
DK0566666T3
DK0566666T3 DK92904197T DK92904197T DK0566666T3 DK 0566666 T3 DK0566666 T3 DK 0566666T3 DK 92904197 T DK92904197 T DK 92904197T DK 92904197 T DK92904197 T DK 92904197T DK 0566666 T3 DK0566666 T3 DK 0566666T3
Authority
DK
Denmark
Prior art keywords
antidiabetic
antiviral
new
inhibitors useful
pct
Prior art date
Application number
DK92904197T
Other languages
Danish (da)
English (en)
Inventor
Robert A Farr
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0566666T3 publication Critical patent/DK0566666T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/567—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with sulfur as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK92904197T 1991-01-10 1991-12-13 Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler DK0566666T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63963591A 1991-01-10 1991-01-10
US78420891A 1991-10-28 1991-10-28
PCT/US1991/009387 WO1992011867A1 (fr) 1991-01-10 1991-12-13 Nouveaux inhibiteurs de glucohydrolase utiles comme agents antidiabetiques

Publications (1)

Publication Number Publication Date
DK0566666T3 true DK0566666T3 (da) 1999-12-06

Family

ID=27093368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904197T DK0566666T3 (da) 1991-01-10 1991-12-13 Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler

Country Status (15)

Country Link
US (1) US5438069A (fr)
EP (1) EP0566666B1 (fr)
JP (1) JP2951723B2 (fr)
KR (1) KR100192862B1 (fr)
AT (1) ATE183100T1 (fr)
AU (1) AU660641B2 (fr)
CA (1) CA2098927A1 (fr)
DE (1) DE69131522T2 (fr)
DK (1) DK0566666T3 (fr)
ES (1) ES2136615T3 (fr)
GR (1) GR3031423T3 (fr)
IE (1) IE920087A1 (fr)
NZ (1) NZ241234A (fr)
PT (1) PT100001B (fr)
WO (1) WO1992011867A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126696T1 (de) * 1985-12-23 1995-09-15 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
AU736668B2 (en) * 1996-10-01 2001-08-02 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (fr) 1997-04-15 1998-10-22 Glycodesign Inc. Sels halogenes d'alcaloide de swainsonine et procedes d'utilisation
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
WO1999021858A1 (fr) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthese de sels de swainsonine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205068A (en) * 1978-05-18 1980-05-27 E. R. Squibb & Sons, Inc. β-Lactamase inhibitor EM4615
EP0056194B1 (fr) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. Pseudo-aminosucres N-substitués, leur préparation et leur utilisation
US4399224A (en) * 1981-07-13 1983-08-16 A. E. Staley Manufacturing Company Enzymatically treated phosphatides
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
EP0104047B1 (fr) * 1982-09-16 1987-07-29 Wako Pure Chemical Industries, Ltd. Oligosaccharides modifiées utilisées comme substrat pour mesurer l'activité de l'alpha-amylase
EP0249008B1 (fr) * 1986-05-09 1993-09-15 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Utilisation de monosaccharides spécifiques pour la préparation d'un médicament pour la prévention des métastases de tumeurs malignes
US4963479A (en) * 1986-10-07 1990-10-16 Hoechst Celanese Corporation Reagent system for an alpha-amylase assay containing aromatic substituted glycoside
US4962097A (en) * 1988-10-28 1990-10-09 Merck & Co., Inc. Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors
US5032505A (en) * 1988-11-21 1991-07-16 Chembiomed, Ltd. Inhibitors for glycosaminosyl transferase V
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use
US5053399A (en) * 1989-02-03 1991-10-01 University Of Pittsburgh Myo-inositol analogs and methods for their use
US5240707A (en) * 1990-04-12 1993-08-31 Merrell Dow Pharma Alpha-mannosidase and fucosidase inhibitors

Also Published As

Publication number Publication date
US5438069A (en) 1995-08-01
EP0566666B1 (fr) 1999-08-11
JP2951723B2 (ja) 1999-09-20
EP0566666A4 (en) 1994-06-08
WO1992011867A1 (fr) 1992-07-23
KR930703013A (ko) 1993-11-29
KR100192862B1 (ko) 1999-06-15
PT100001B (pt) 1999-06-30
ES2136615T3 (es) 1999-12-01
IE920087A1 (en) 1992-07-15
DE69131522T2 (de) 1999-11-25
AU660641B2 (en) 1995-07-06
EP0566666A1 (fr) 1993-10-27
GR3031423T3 (en) 2000-01-31
DE69131522D1 (de) 1999-09-16
AU9176091A (en) 1992-08-17
NZ241234A (en) 1994-07-26
CA2098927A1 (fr) 1992-07-11
ATE183100T1 (de) 1999-08-15
PT100001A (pt) 1993-02-26
JPH06504550A (ja) 1994-05-26

Similar Documents

Publication Publication Date Title
DK0724435T3 (da) Amidinoderivater, der er nyttige som nitrogenoxid-synthase-inhibitorer
TW349843B (en) Substituted 1-arylpyrazoles
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
NO975716L (no) Imidazolforbindelser
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
SE9604793D0 (sv) New polymorphs
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
DK0941221T3 (da) Substituerede dihydrobenzofuraner som PDE-inhibitorer
DK0799239T3 (da) Diastereomert rene 3-oxo- og 3-thioxo-4-aza-androstan-derivater og anvendelse deraf som antiandrogener
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
DK0579681T3 (da) Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DK0824350T3 (da) Anvendelse af et antimykotikum
DK0566666T3 (da) Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler
DK0588796T3 (da) Sampanginderivater til anvendelse som antifungiske og antimykobakterielle midler
FR2707990B1 (fr) Nouvelles nitrones utilisables pour le piégeage des radicaux libres.
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
ES2147282T3 (es) Utilizacion de al menos un carburo terpenico y/o uno de sus derivados como adyuvante de un caldo herbicida o coformulante de una composicion herbicida
ATE138662T1 (de) Antibiotische 7-aminonaphthazarinderivate
FI962301A0 (fi) Substituoidut aminoalkyyliaminopyridiinit
ES2074250T3 (es) Azocolorantes, procedimiento para su preparacion y su empleo.
ATE227571T1 (de) Thrombin inhibitoren
DK0659184T3 (da) Optisk aktivt hydroquinin-1-(3-aminophenyl)-ethansulfonat samt fremstilling og anvendelse deraf